U

SciTech Development

Introducing Our Lead Cancer Drug Candidate ST-001 nanoFenretinide and New Drug Delivery Platform.
Multinational United States
Last Update Dec 27, 2024

SciTech Development Financials

Total funding
Capital raised
Last funding
Funding stage
Total rounds
Investors